Back to today’s briefing

Story perspectives

Genetic Testing for Alzheimer's: Hope and Risks Unveiled

6/20/2025

34 4

Summary

Story summary

Genetic testing for Alzheimer’s, especially for the ApoE4 gene, opens doors to early diagnosis and proactive care. While promising drugs like Leqembi and Kisunla bring hope, they also pose risks for ApoE4 carriers. Experts urge individuals to thoughtfully assess their emotional readiness and family history, as this knowledge can be both empowering and daunting.

1 of 1

Story summary

Genetic testing for Alzheimer’s, especially for the ApoE4 gene, opens doors to early diagnosis and proactive care. While promising drugs like Leqembi and Kisunla bring hope, they also pose risks for ApoE4 carriers. Experts urge individuals to thoughtfully assess their emotional readiness and family history, as this knowledge can be both empowering and daunting.